Hypothyroidism: A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma

Cancer

Volumn 92, Issue 11, 2001, Pages 2892-2897

  Mercado, Gina ^a   Adelstein, David J ^b   Saxton, Jerrold P ^b   Secic, Michelle ^b   Larto, Marjorie A ^b   Lavertu, Pierre ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chemoradiotherapy; Chemotherapy; Head and neck carcinoma; Hypothyroidism; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL; THYROTROPIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOTHYROIDISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; DRUG THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOTHYROIDISM; INCIDENCE; MALE; MIDDLE AGED; RADIOTHERAPY; RETROSPECTIVE STUDIES;

EID: 0035576005     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011201)92:11<2892::AID-CNCR10134>3.0.CO;2-T     Document Type: Article

References (33)

1. A Phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable Stage III and W squamous cell head and heck cancer: Preliminary results
2. Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck
3. Hypopituitarism after external radiation. Evidence for both hypothalamic and pituitary origin
4. Hypothyroidism complicating combined modality therapy for head and neck malignancy
5. Hypothyroidism following treatment for head and neck cancer
6. Hypothyroidism and wound healing: Occurrence after head and neck radiation and surgery
7. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck
8. Thwoid function following radiation and surgical therapy in head and neck malignancy
9. Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck
10. Endocrine complications after radiotherapy for tumors of the head and neck
11. Hypothyroidism following radiotherapy for head and neck cancer: Multivariate analysis of risk factors
12. Hypothyroidism in head and neck cancer patients: Experimental and clinical observation
13. Thyroid dysfunction following radiotherapy for head and neck cancer
14. What else don't we know about the late effects of radiation in patients treated for head and neck cancer?
15. A prospective analysis of subacute thyroid dysfunction after neck irradiation
16. Hypothyroidism after external radiotherapy for head and neck cancer
17. Disorders of endocrine function following cancer therapies
18. Thyroid irradiation and carcinogenesis. Review with assessment of clinical implications
19. Radiation and thyroid disease
20. Thyroid abnormalities after therapeutic external radiation
21. Radiation-related thyroid dysfunction: Implications for the treatment of Hodgkin's disease
22. Thyroid abnormalities associated with treatment of malignant lymphoma
23. Thyroid diseases after the treatment of Hodgkin's disease
24. Hypothyroidism after X irradiation to the neck: Three case reports and a brief review of the literature
25. Thyroid-stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer
26. Hypothyroidism after treatment for nonthyroid head and neck cancer
27. Hypothyroidism following combined therapy in carcinoma of the laryngophaynx
28. Thyroid function after radiation and surgery for head and neck cancer
29. Hypothyroidism following radiotherapy for head and neck cancer
30. Thyroid dysfunction after radiation therapy in head and neck cancer patients
31. Complications associated with therapeutic neck radiation
32. Postradiotherapy hypothyroidism: Radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy
33. Report of an association between race and thyroid stimulating hormone level